AMGN compared with SGMOQ: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

SGMOQSangamo Therapeutics, Inc

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

SGMOQSangamo Therapeutics, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

466.31▲+1.21%· post 466.40

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

SGMOQSangamo Therapeutics, Inc

ClosedOct 30 '26

Mkt cap$48.1MRevenue$1MQ1 FY26Revenue$40MFY25

Compare

ClosedOct 30 '26

AMGNAmgen Inc

SGMOQSangamo Therapeutics, Inc

466.31▲+1.21%post 466.40

Price

$251.9B

Mkt cap

$48.1M

Q2 FY26$10.1B

Revenue

$1MQ1 FY26

FY25$36.8B

Revenue

$40MFY25

AMGN466.31▲+1.21%vsSGMOQClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SGMOQ: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

AMGN, solidSGMOQ, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only SGMOQ 4

—Alexion Pharmaceuticalsunlistedcustomer

—Astellas Gene Therapiesunlistedcustomer

—Eli Lillyunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Genentechunlistedcustomer